Charles River Laboratories Acquires KWS BioTest

To learn more click here.

Introduction to KWS BioTest

KWS BioTest’s CEO Dr Robin Brown and CSO Professor Neil Williams discuss the company’s services

Read video transcription

Featured: Clinical Biomarkers

At KWS BioTest we have extensive experience in mapping immune function in the clinic.

Read more about our Clinical Biomarkers

Featured: Immuno-oncology

KWS BioTest’s expertise in immunology is invaluable for clients developing compounds designed to modulate anti-tumour immunity

Read about our Immuno-oncology expertise

Latest from the blog: EXPERT INSIGHT: Tumour Immunogenicity- the key to predicting immune checkpoint blockade efficacy

Read more